| 000 | 01086 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516211707.0 | ||
| 264 | 0 | _c20140505 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1731-2302 | ||
| 024 | 7 |
_a10.1186/1897-4287-12-12 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGrindedal, Eli Marie | |
| 245 | 0 | 0 |
_aThe Norwegian PMS2 founder mutation c.989-1G > T shows high penetrance of microsatellite instable cancers with normal immunohistochemistry. _h[electronic resource] |
| 260 |
_bHereditary cancer in clinical practice _c2014 |
||
| 300 |
_a12 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aAarset, Harald | |
| 700 | 1 | _aBjørnevoll, Inga | |
| 700 | 1 | _aRøyset, Elin | |
| 700 | 1 | _aMæhle, Lovise | |
| 700 | 1 | _aStormorken, Astrid | |
| 700 | 1 | _aHeramb, Cecilie | |
| 700 | 1 | _aMedvik, Heidi | |
| 700 | 1 | _aMøller, Pål | |
| 700 | 1 | _aSjursen, Wenche | |
| 773 | 0 |
_tHereditary cancer in clinical practice _gvol. 12 _gno. 1 _gp. 12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1897-4287-12-12 _zAvailable from publisher's website |
| 999 |
_c23790413 _d23790413 |
||